The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

TYRA FINANCIAL STATEMENTS

Tyra Biosciences Inc — balance sheet, income statement and cash flow trends

TYRATyra Biosciences Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-150 M-100 M-50 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-270 K $ · -Infinity%Operating Income-160.5 M $ · -Infinity%Pre-tax Income-148.6 M $ · -Infinity%Net Income to Owners-148.6 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $-100.0%
Gross Profit-270 K $—
Operating Income-160.5 M $—
EBITDA-148 M $—
Net Income to Owners-148.6 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets383.4 M
  • Equity353.7 M $92%
  • Current Liabilities24.6 M $6%
  • Long-term Liabilities5.1 M $1%

Key Figures

YoY change
Total Assets383.4 M $+19.2%
Total Liabilities29.7 M $+53.5%
Total Equity353.7 M $+17.1%
Cash & ST Investments353.9 M $+19.5%
Total Debt5.6 M $-7.3%
Net Debt-68.3 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-100 M-50 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-200 M-100 M0-109.7 M $Operating-82.8 M $Investing167.8 M $Financing-24.7 M $Net Change

Key Figures

YoY change
Operating Cash Flow-109.7 M $—
Capital Expenditures250 K $+142.7%
Free Cash Flow-109.9 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on TYRA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.